Literature DB >> 16645455

Orexins increase cortical acetylcholine release and electroencephalographic activation through orexin-1 receptor in the rat basal forebrain during isoflurane anesthesia.

Hai-long Dong1, Satoru Fukuda, Eri Murata, Zhenghua Zhu, Takashi Higuchi.   

Abstract

BACKGROUND: Cholinergic arousal system plays an important role in the maintenance of consciousness. The authors investigated whether the intrabasalis injection of orexin-A or orexin-B and the electrically stimulated pedunculopontine tegmentum nuclei (PPTg: the origin of cholinergic ascending pathways) may alter acetylcholine efflux and electroencephalographic activity in the somatosensory cortex in relation to the orexinergic system in isoflurane-anesthetized rats.
METHODS: Either orexin-A (10, 30, or 100 pmol) or orexin-B (10, 30, or 100 pmol) (n = 6 each) was injected into the basal forebrain while the electroencephalogram was measured during 1.0 minimum alveolar concentration (1.2%) isoflurane anesthesia. Injection of Ringer's solution was used as a control. The PPTg was electrically stimulated twice with the following conditions: 1-s stimulus train (0.2 ms, 100 Hz, 400 microA) per min for 20 min. Twenty minutes before the second PPTg stimulation, Ringer's solution or 20 microg SB334867, an orexin-1 receptor antagonist (n = 5 each) was injected into the basal forebrain.
RESULTS: Injection of orexin-A (30 and 100 pmol) and orexin-B (100 pmol) significantly increased the acetylcholine efflux in the somatosensory cortex (P < 0.05). Injection of orexin-A (10, 30, 100 pmol) and orexin-B (30, 100 pmol) changed the burst and suppression patterns to arousal electroencephalogram. Compared with orexin-B, injection of a lower dose of orexin-A induced increase in the acetylcholine efflux and arousal electroencephalogram. SB334867 significantly attenuated the increases in the acetylcholine efflux and electroencephalographic activation evoked by PPTg stimulation.
CONCLUSION: The authors demonstrated that orexin-A was more potent than orexin-B in producing alteration of cholinergic basal forebrain neuronal activity and that the cortical activation induced by the PPTg stimulation against isoflurane anesthesia may be mediated through the orexin-1 receptors in the basal forebrain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16645455     DOI: 10.1097/00000542-200605000-00019

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  19 in total

1.  Neuropharmacology of Sleep and Wakefulness.

Authors:  Christopher J Watson; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep Med Clin       Date:  2010-12

Review 2.  Orexin/hypocretin modulation of the basal forebrain cholinergic system: Role in attention.

Authors:  J Fadel; J A Burk
Journal:  Brain Res       Date:  2009-08-21       Impact factor: 3.252

3.  The arousal effect of hyperbaric oxygen through orexin/hypocretin an upregulation on ketamine/ethanol-induced unconsciousness in male rats.

Authors:  Hetao Bian; Lei Huang; Bo Li; Qin Hu; Xiping Liang; Jiping Tang; John H Zhang
Journal:  J Neurosci Res       Date:  2019-03-21       Impact factor: 4.164

Review 4.  Escape From Oblivion: Neural Mechanisms of Emergence From General Anesthesia.

Authors:  Max B Kelz; Paul S García; George A Mashour; Ken Solt
Journal:  Anesth Analg       Date:  2019-04       Impact factor: 5.108

5.  Increased acetylcholine and glutamate efflux in the prefrontal cortex following intranasal orexin-A (hypocretin-1).

Authors:  Coleman B Calva; Habiba Fayyaz; Jim R Fadel
Journal:  J Neurochem       Date:  2018-01-12       Impact factor: 5.372

6.  Neuropharmacology of Sleep and Wakefulness: 2012 Update.

Authors:  Christopher J Watson; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep Med Clin       Date:  2012-09-04

Review 7.  Intranasal administration of orexin peptides: Mechanisms and therapeutic potential for age-related cognitive dysfunction.

Authors:  Coleman B Calva; Jim R Fadel
Journal:  Brain Res       Date:  2018-08-24       Impact factor: 3.252

8.  Systemic and intrabasalis administration of the orexin-1 receptor antagonist, SB-334867, disrupts attentional performance in rats.

Authors:  Karen E Boschen; Jim R Fadel; Joshua A Burk
Journal:  Psychopharmacology (Berl)       Date:  2009-07-03       Impact factor: 4.530

9.  The role of spinal orexin-1 receptors in posterior hypothalamic modulation of neuropathic pain.

Authors:  Y Jeong; J E Holden
Journal:  Neuroscience       Date:  2009-02-11       Impact factor: 3.590

10.  Intraventricular orexin-A improves arousal and early EEG entropy in rats after cardiac arrest.

Authors:  Matthew A Koenig; Xiaofeng Jia; Xiaoxu Kang; Adrian Velasquez; Nitish V Thakor; Romergryko G Geocadin
Journal:  Brain Res       Date:  2008-12-16       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.